Torrent Pharma's Profit Picks Up By 6% In Q1 Results

Torrent Pharma reported its quarter-one earnings on Monday, the pharma major has recorded sales worth Rs 2,591 crores for the quarter that ended in June 2023, a 10 per cent rise over the same quarter in the previous year. 

The company's Profit After Tax (PAT) rose by 6 per cent YoY to Rs 378 crores against Rs 354 crores in the corresponding quarter of the previous year.

The company’s sales in the US saw a drop of 2 per cent YoY to Rs 293 crore. At the same time, the sales in Germany were up by 21 per cent YoY and stood at Rs 253 crore.

The pharma company recorded an 11 per cent rise year on year in EBITDA and stood at Rs 791 crores, while the EBITDA margins for the first quarter were recorded at 31 against 30 per cent in the corresponding quarter last year.

Torrent Pharma's R&D investments also saw a 6 per cent YoY boost in the June quarter, it was recorded at Rs 129 crore against Rs 120 crore in the same quarter last year.